Mediators of Inflammation

Regulation of Cytokines in Cancer Pain


Publishing date
11 Dec 2015
Status
Published
Submission deadline
24 Jul 2015

Lead Editor

1Parker University Research Institute, Dallas, USA

2Yale University, New Haven, USA

3Northwestern University, Chicago, USA


Regulation of Cytokines in Cancer Pain

Description

Cancer pain poses a major challenge in clinical treatment; yet its underlying mechanisms remain elusive. Recent advances in understanding the molecular pathways mediating the inflammatory processes accompanying cancer and cancer pain suggest the importance of proinflammatory cytokines. Further studies in this area will facilitate the discovery and validation of potential therapeutic targets for cancer pain.

We invite investigators to submit original research articles as well as review articles that seek to understand the roles of cytokines in the development and maintenance of cancer pain. We are interested in both human clinical studies and preclinical studies using animal models.

Potential topics include, but are not limited to:

  • Mechanisms and management of cancer pain
  • Treatment of cancer pain by targeting cytokines
  • Peripheral regulation of cytokines in cancer pain
  • Spinal and supraspinal regulation of cytokines in cancer pain
  • Clinical investigations and management of cancer pain
  • Use of electrical stimulation of peripheral nerve, spinal cord, and/or brain and of Chinese herbs for treating cancer pain

Articles

  • Special Issue
  • - Volume 2016
  • - Article ID 2741205
  • - Editorial

Regulation of Cytokines in Cancer Pain

Xue-Jun Song | Robert H. LaMotte | Zhong Xie
  • Special Issue
  • - Volume 2016
  • - Article ID 5093095
  • - Research Article

Radiotherapy Suppresses Bone Cancer Pain through Inhibiting Activation of cAMP Signaling in Rat Dorsal Root Ganglion and Spinal Cord

Guiqin Zhu | Yanbin Dong | ... | Xue-Jun Song
  • Special Issue
  • - Volume 2015
  • - Article ID 752512
  • - Research Article

Levo-Tetrahydropalmatine Attenuates Bone Cancer Pain by Inhibiting Microglial Cells Activation

Mao-yin Zhang | Yue-peng Liu | ... | Su Liu
  • Special Issue
  • - Volume 2015
  • - Article ID 265056
  • - Research Article

Sigma-1 Receptor Antagonist BD1047 Reduces Mechanical Allodynia in a Rat Model of Bone Cancer Pain through the Inhibition of Spinal NR1 Phosphorylation and Microglia Activation

Shanshan Zhu | Chenchen Wang | ... | Yannan Liu
  • Special Issue
  • - Volume 2015
  • - Article ID 129034
  • - Review Article

Cytokines as Mediators of Pain-Related Process in Breast Cancer

Carolina Panis | Wander Rogério Pavanelli
  • Special Issue
  • - Volume 2015
  • - Article ID 961635
  • - Clinical Study

A Traditional Chinese Medicine Xiao-Ai-Tong Suppresses Pain through Modulation of Cytokines and Prevents Adverse Reactions of Morphine Treatment in Bone Cancer Pain Patients

Yan Cong | Kefu Sun | ... | Xue-Jun Song
  • Special Issue
  • - Volume 2015
  • - Article ID 439014
  • - Clinical Study

Efficacy and Safety of Ropivacaine Addition to Intrathecal Morphine for Pain Management in Intractable Cancer

Ying Huang | Xihan Li | ... | Gaojian Tao
  • Special Issue
  • - Volume 2015
  • - Article ID 523896
  • - Research Article

Inducible Lentivirus-Mediated siRNA against TLR4 Reduces Nociception in a Rat Model of Bone Cancer Pain

Ruirui Pan | Huiting Di | ... | Feixiang Wu
  • Special Issue
  • - Volume 2015
  • - Article ID 984570
  • - Review Article

Treatment of Cancer Pain by Targeting Cytokines

I. Vendrell | D. Macedo | ... | L. Costa
Mediators of Inflammation
 Journal metrics
Acceptance rate36%
Submission to final decision53 days
Acceptance to publication29 days
CiteScore6.000
Impact Factor3.758
 Submit

We are committed to sharing findings related to COVID-19 as quickly as possible. We will be providing unlimited waivers of publication charges for accepted research articles as well as case reports and case series related to COVID-19. Review articles are excluded from this waiver policy. Sign up here as a reviewer to help fast-track new submissions.